695 related articles for article (PubMed ID: 9554190)
1. The diagnostic utility of dual phase Tc-99m sestamibi parathyroid imaging.
Klieger P; O'Mara R
Clin Nucl Med; 1998 Apr; 23(4):208-11. PubMed ID: 9554190
[TBL] [Abstract][Full Text] [Related]
2. Tc-99m sestamibi parathyroid gland scintigraphy: added value of Tc-99m pertechnetate thyroid imaging for increasing interpretation confidence and avoiding additional testing.
Powell DK; Nwoke F; Goldfarb RC; Ongseng F
Clin Imaging; 2013; 37(3):475-9. PubMed ID: 23102932
[TBL] [Abstract][Full Text] [Related]
3. Preoperative imaging of abnormal parathyroid glands in patients with hyperparathyroid disease using combination Tc-99m-pertechnetate and Tc-99m-sestamibi radionuclide scans.
Wei JP; Burke GJ; Mansberger AR
Ann Surg; 1994 May; 219(5):568-72; discussion 572-3. PubMed ID: 8185405
[TBL] [Abstract][Full Text] [Related]
4. Prospective comparison of technetium-99m-sestamibi/iodine-123 radionuclide scan versus high-resolution ultrasonography for the preoperative localization of abnormal parathyroid glands in patients with previously unoperated primary hyperparathyroidism.
Casas AT; Burke GJ; Sathyanarayana ; Mansberger AR; Wei JP
Am J Surg; 1993 Oct; 166(4):369-73. PubMed ID: 8214295
[TBL] [Abstract][Full Text] [Related]
5. The usefulness of Tc-99m tetrofosmin scintigraphy in the diagnosis and localization of hyperfunctioning parathyroid glands.
Vallejos V; Martin-Comin J; Gonzalez MT; Rafecas R; Muñoz A; Fernãndez A; Mora J; Ramos M
Clin Nucl Med; 1999 Dec; 24(12):959-64. PubMed ID: 10595477
[TBL] [Abstract][Full Text] [Related]
6. Clinical role of 99mTcO4/MIBI scan, ultrasound and intra-operative gamma probe in the performance of unilateral and minimally invasive surgery in primary hyperparathyroidism.
Casara D; Rubello D; Pelizzo MR; Shapiro B
Eur J Nucl Med; 2001 Sep; 28(9):1351-9. PubMed ID: 11585294
[TBL] [Abstract][Full Text] [Related]
7. Comparison between 99mTc-tetrofosmin/pertechnetate subtraction scintigraphy and 99mTc-tetrofosmin SPECT for preoperative localization of parathyroid adenoma in an endemic goiter area.
Gallowitsch HJ; Mikosch P; Kresnik E; Unterweger O; Lind P
Invest Radiol; 2000 Aug; 35(8):453-9. PubMed ID: 10946972
[TBL] [Abstract][Full Text] [Related]
8. Technetium-99m-sestamibi single agent localization versus high resolution ultrasonography for the preoperative localization of parathyroid glands in patients with primary hyperparathyroidism.
Billy HT; Rimkus DR; Hartzman S; Latimer RG
Am Surg; 1995 Oct; 61(10):882-8. PubMed ID: 7668462
[TBL] [Abstract][Full Text] [Related]
9. Parathyroid 99mTc-sestamibi scintigraphy: dual-tracer subtraction is superior to double-phase washout.
Leslie WD; Dupont JO; Bybel B; Riese KT
Eur J Nucl Med Mol Imaging; 2002 Dec; 29(12):1566-70. PubMed ID: 12458389
[TBL] [Abstract][Full Text] [Related]
10. Double-phase Tc-99m sestamibi scintigraphy in the preoperative location of lesions causing hyperparathyroidism.
Blanco I; Carril JM; Banzo I; Quirce R; Gutierrez C; Uriarte I; Montero A; Vallina NK
Clin Nucl Med; 1998 May; 23(5):291-7. PubMed ID: 9596153
[TBL] [Abstract][Full Text] [Related]
11. Impact of technetium-99m-sestamibi localization on operative time and success of operations for primary hyperparathyroidism.
Casas AT; Burke GJ; Mansberger AR; Wei JP
Am Surg; 1994 Jan; 60(1):12-6; discussion 16-7. PubMed ID: 8273968
[TBL] [Abstract][Full Text] [Related]
12. The efficacy of sestamibi parathyroid scintigraphy for directing surgical approaches based on modified interpretation criteria.
Kim CK; Kim S; Krynyckyi BR; Machac J; Inabnet WB
Clin Nucl Med; 2002 Apr; 27(4):246-8. PubMed ID: 11914662
[TBL] [Abstract][Full Text] [Related]
13. Comparison of parathyroid imaging with technetium-99m-pertechnetate/sestamibi subtraction, double-phase technetium-99m-sestamibi and technetium-99m-sestamibi SPECT.
Chen CC; Holder LE; Scovill WA; Tehan AM; Gann DS
J Nucl Med; 1997 Jun; 38(6):834-9. PubMed ID: 9189125
[TBL] [Abstract][Full Text] [Related]
14. Usefulness of combination of high-resolution ultrasonography and dual-phase dual-isotope iodine 123/technetium Tc 99m sestamibi scintigraphy for the preoperative localization of hyperplastic parathyroid glands in renal hyperparathyroidism.
Périé S; Fessi H; Tassart M; Younsi N; Poli I; St Guily JL; Talbot JN
Am J Kidney Dis; 2005 Feb; 45(2):344-52. PubMed ID: 15685513
[TBL] [Abstract][Full Text] [Related]
15. Dual-phase 99mTc-sestamibi imaging: its utility in parathyroid hyperplasia and use of immediate/delayed image ratios to improve diagnosis of hyperparathyroidism.
Gordon L; Burkhalter W; Mah E
J Nucl Med Technol; 2002 Dec; 30(4):179-84. PubMed ID: 12446751
[TBL] [Abstract][Full Text] [Related]
16. Technetium-99m-sestamibi/pertechnetate subtraction scintigraphy vs ultrasonography for preoperative localization in primary hyperparathyroidism.
Berczi C; Mezõsi E; Galuska L; Varga J; Bajnok L; Lukács G; Balázs G
Eur Radiol; 2002 Mar; 12(3):605-9. PubMed ID: 11870476
[TBL] [Abstract][Full Text] [Related]
17. The complementary roles of fast spin-echo MR imaging and double-phase 99m Tc-sestamibi scintigraphy for localization of hyperfunctioning parathyroid glands.
Lee VS; Spritzer CE; Coleman RE; Wilkinson RH; Coogan AC; Leight GS
AJR Am J Roentgenol; 1996 Dec; 167(6):1555-62. PubMed ID: 8956597
[TBL] [Abstract][Full Text] [Related]
18. Parathyroid imaging with pertechnetate plus perchlorate/MIBI subtraction scintigraphy: a fast and effective technique.
Rubello D; Saladini G; Casara D; Borsato N; Toniato A; Piotto A; Bernante P; Pelizzo MR
Clin Nucl Med; 2000 Jul; 25(7):527-31. PubMed ID: 10885694
[TBL] [Abstract][Full Text] [Related]
19. The accuracy of parathyroid gland localization in primary hyperparathyroidism using sestamibi radionuclide imaging.
Johnston LB; Carroll MJ; Britton KE; Lowe DG; Shand W; Besser GM; Grossman AB
J Clin Endocrinol Metab; 1996 Jan; 81(1):346-52. PubMed ID: 8550776
[TBL] [Abstract][Full Text] [Related]
20. Comparison of hyperparathyroidism types and utility of dual radiopharmaceutical acquisition with Tc99m sestamibi and
Kushchayeva YS; Tella SH; Kushchayev SV; Van Nostrand D; Kulkarni K
Osteoporos Int; 2019 May; 30(5):1051-1057. PubMed ID: 30706095
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
